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Abstract Ethylene glycol ethers (EGEs) are components
of many industrial and household products. Their hemo-
lytic and gonadotoxic effects are relatively well known
while their potential adverse effects on the central nervous
system have not yet been clearly demonstrated. The aim of
the present study was to examine the effects of 4-week
administration of 2-buthoxyethanol (BE), 2-phenoxyetha-
nol (PHE) and 2-ethoxyethanol (EE) on the total antioxi-
dant capacity, activity of some antioxidant enzymes, such
as the superoxide dismutase (SOD), catalase, glutathione
peroxidase (GPX) and glutathione reductase and lipid
peroxidation in the frontal cortex and hippocampus in the
rat. These studies showed that BE and PHE decreased the
total antioxidant activity, SOD and GPX activity, while
increased lipid peroxidation in the frontal cortex. Like in
the frontal cortex, also in the hippocampus BE and PHE
attenuated the total antioxidant activity, however, lipid
peroxidation was increased only in animals which received
BE while reduction in GPX activity was present in rats
administered PHE. The obtained data indicated that 4-week
administration of BE and PHE, but not EE, reduced the
total antioxidant activity and enhanced lipid peroxidation
in the brain. In the frontal cortex, adverse effects of PHE
and BE on lipid peroxidation probably depended on
reduction in SOD and GPX activity, however, in the hip-
pocampus the changes in the total antioxidant activity and
lipid peroxidation were not connected with reduction of the
investigated antioxidant enzyme activity.
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Introduction
Ethylene glycol ethers (EGEs) are ingredients of many
industrial, household and pharmaceutical products. EGEs
possess advantageous physicochemical properties, like low
vapor pressure, solubility in ethanol and water mixtures
which makes them a superb solvent with multiple appli-
cations (Boatman and Knaak 2001). Hence, they are used
in cooling liquids, varnishes, pesticides, herbicides,
household liquids, vaccines or antiseptic specifics and
many others. The most broadly known EGEs include:
2-methoxyethanol (ME), 2-ethoxyethanol (EE), 2-buth-
oxyethanol (BE), 2-propoxyethanol (PE), 2-isopropoxy-
ethanol (IPE) and 2-phenoxyethanol (PHE). EGEs are well
absorbed following dermal, inhalation or oral exposures
and are quickly distributed throughout the body (Hardin
et al. 1984; Ku et al. 1995; Lockley et al. 2002; Udden
2000). Many studies, both, in vitro and in vivo have shown
that these compounds exert toxic influence on reproductive,
developmental, immunological and hematological systems
(Barbee et al. 1984; Johanson 2000; Lamb et al. 1984;
Starek et al. 2008a; Williams et al. 1995). It has been
proven that in vivo EGEs are metabolized mainly via
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oxidation by alcohol dehydrogenase to alkoxyacetaldehyde
and next are converted by aldehyde dehydrogenase to
alkoxyacetic acid (Ghanayem et al. 1987; Ma et al. 1993).
Toxic effect of EGEs in the periphery is exerted predom-
inantly by their metabolites, mainly alkoxyacetic acids
(Ghanayem and Sullivan 1993). Short-chain EGEs, e.g.
ME and EE have predominantly gonadotoxic effect. In
male rats, ME and EE disrupted testicular function by
causing degeneration of spermatocytes and reduction of the
number of spermatocytes and spermatids in the experi-
mental model of intoxication (Adedara and Farombi 2010;
Lamb et al. 1984). In female rats, these compounds caused
toxic effect mainly on ovarian luteal cells (Davis et al.
1997). People with occupational exposure to EE and ME
suffered from disturbance in menstrual cycle in women and
reduction in sperm count in men (Gold 1995; Welch 1988).
Contrary to ME and EE, BE and IPE exert a potent
hemolytic effect. Such effect has been reported not only in
experimental animals, but also in clinical observations of
patients intoxicated with BE or IPE (Ghanayem and Sul-
livan 1993; Starek et al. 2008a, b). These EGEs signifi-
cantly reduced the red blood cell, thrombocyte and
leukocyte counts and hemoglobin level. It has been also
reported that these compounds caused bone marrow sup-
pression (Haufroid et al. 1997; Kim et al. 1999) and exerted
toxic effects on the immune system.
The toxic effects of EGEs on the hematopoietic system,
reproductive system, immune system are relatively well-
described, whereas the studies of a potential neurotoxicity
of these compounds are very scanty, yet. Clinical obser-
vations of intoxicated patients showed that EGEs affected
brain function and depending on the dose caused headache,
impairment of cognitive function, disturbed motor coor-
dination, convulsions or central nervous system depression
(Ahmed et al. 1983; Morton 1990; Ohi and Wegman
1978). It is known that EGEs cross the blood–brain barrier,
so their adverse effect on the CNS and involvement in
triggering and progress of neurodegenerative changes is
highly probable. Previously in in vitro experiments we
found that BE, PHE and IPE more severely than ME or EE
damaged human neuroblastoma cells (SH-SY5Y). Those
experiments indicated that more lipophilic EGEs like BE
or PHE are more harmful to neurons than those EGEs with
higher hydrophilic properties (Regulska et al. 2010). In the
next experiment, we showed that also in vivo a mixture of
two EGEs induced adverse reactions in the brain by
decreasing the total antioxidant capacity, enhancing lipid
peroxidation and increasing caspase-3 activity in the rat
hippocampus and frontal cortex (Pomierny et al. 2013).
However, in that study we examined the action of com-
bined administration of two EGEs, with different chain
lengths, since industrial and household products most often
contain EGE mixture.
The aim of the present study was to examine a potential
toxic effect of BE, PHE and EE on the rat hippocampus
and frontal cortex. Since oxidative stress is considered to
be a major factor involved in induction of nerve cell
damage, the effect of EGEs on the total antioxidant
capacity, activity of antioxidant enzymes (superoxide dis-
mutase, catalase, glutathione peroxidase and glutathione
reductase) and lipid peroxidation was determined. PHE
was chosen for this study, because this compound exerted
the most potent cytotoxic effect on SH-SY5Y cells and its
potential neurotoxic activity has not been investigated so
far, either alone or in a mixture, in in vivo models.
Moreover, phenoxyacetic acid, a PHE metabolite, occurs in
the urine of general population and after exposure to
preparations containing PHE during cleaning procedures its
concentration is the highest, and, therefore, it creates the
greatest risk (Fromme et al. 2013). BE was selected
because it strongly enhanced oxidative stress-induced
damage of SH-SY5Y cells and administered to rats in a
mixture with ME or EE evoked oxidative stress in the
brain. Moreover, production of BE has increased in recent
years to replace gonadotoxic ME and EE and now more
than a half of household preparations contains BE. Con-
trary to PHE and BE, which have a clearly lipophilic
character and, therefore, are more likely to pass into the
brain, EE is more hydrophilic and should exert a weaker
effect in the brain. However, we included it in this study,
because there are no experimental data concerning its level
and action in the brain, so its potential adverse effects
cannot be excluded and additionally the mechanism of
action of this compound in peripheral tissues is the best
known, so far. For example, it has been found that EE
decreased glutathione level, superoxide dismutase and
catalase activity and enhanced lipid peroxidation in the rat
testes (Adedara and Farombi 2010), so it potentiated oxi-
dative stress, crucially involved also in brain cell damage.
The potential adverse effect of 4-week administration of
the selected EGEs on oxidative stress markers and lipid
peroxidation was evaluated in the hippocampus and frontal
cortex since these brain region are more susceptible to
damage.
Materials and Methods
Animals
The experiments were performed on male Wistar rats
(250–330 g). The animals were kept under natural day-
night cycle, at 22 ± 2 C with food and water available at
libitum. All procedures were conducted according to the
NIH Guide for the Care and Use of Laboratory Animals
and were approved by the Local Ethics Committee. The
Neurotox Res (2014) 26:422–429 423
123
rats were randomly divided into five groups of eight ani-
mals each (n = 8). Animals were treated subcutaneously
with saline, EE (2.5 mM/kg), BE (2.5 mM/kg), sunflower
oil and PHE (2.5 mM/kg) once a day, 5 days per week, for
4 weeks. Due to the solubility of PHE in the sunflower oil,
there were two control groups—receiving saline or sun-
flower oil. All the solutions were sterile and neutralized to
pH of 7.4. The volume of solution administered to each
animal was in the range of 250–330 ll as the solution was
prepared at the concentration of 2.5 mM/ml. The rats were
treated with the examined compounds 5 days per week in
order to model workers’ exposure. We did not notice any
escalated behavioral pain response after first as well as
subsequent injections. After animals were sacrificed we
examined subdermal tissue in the place of injections (lower
middle part of the groin) to any signs of inflammation, with
negative results.
It should be noted that stress connected with repeated,
subcutaneous administration of EGEs can modulate the
activity of investigated antioxidant enzymes and lipid
peroxidation, so the effect of test compounds was com-
pared to appropriate parameters obtained in animals
receiving the solvent alone, respectively saline or oil, and
subjected to the same procedures as animals injected with
compounds tested.
The animals were decapitated 24 h after the last injec-
tion and their brains were quickly removed from the skull.
The frontal cortex and hippocampus were isolated at low
temperature (on ice) and immediately frozen on dry ice and
stored at -80 C until they were used for biochemical
assays. Tissues were dissected out according to The Rat
Brain Atlas (G. Paxinos, C. Watson, The Rat Brain in
Stereotaxic Coordinates, fourth ed., Academic Press, San
Diego, 1998). Frozen brain tissues were homogenized in
50 mM phosphate buffer solution (pH = 7.4).
Each control and experimental groups contained eight
samples and each sample was determined in triplicates.
Total Antioxidant Capacity (TAC)
Analysis of TAC was carried out on the brain structure
homogenates according to the modified method of Benzie
and Strain (1996) adapted to specific tissue and microplate
assay. The tissue antioxidant ability was evaluated by
reduction of ferric ions. Fe(III)–tripyridyltriazine (Fe(III)–
TPTZ) complex is reduced to blue Fe(II)–tripyridyltriazine
(Fe(II)–TPTZ), the level of which was determined spec-
trophotometrically at 573 nm. The absorbance was mea-
sured by a multiwell plate reader (TECAN Infinite M200).
The total antioxidant capacity of samples was calculated
from the standard curve and was expressed as mM Fe(II)
per mg of protein.
Superoxide Dismutase (SOD) Activity
The assay uses the xanthine/xanthine oxidase (XOD) sys-
tem as a source of superoxide anions which reduce the
nitroblue tetrazolium salt to a water-soluble formazan. The
method is based on the principle, that SOD decomposes
superoxide anions and thus inhibits formazan formation.
The chromogen level in the sample was determined spec-
trophotometrically with absorption maximum at 560 nm.
Since the level of SOD in the sample is proportional to the
assay reaction inhibition, the results are expressed as the
inhibition rate in %.
Catalase (CAT) Activity
Catalase activity was determined by Catalase Assay Kit
(Cayman, US). The method is based on the reaction of
tissue homogenate catalase in the presence of methanol and
optimal concentration of H2O2. The product of this reac-
tion, which is formaldehyde, reacts with a specific chro-
mogen to form purple heterocyclic compound with
maximal absorbance at 540 nm. Catalase activity in sam-
ples was calculated from the standard curve and was
expressed as U/mg of protein.
Glutathione Peroxidase (GPx) Activity
The activity of GPx was measured indirectly by a coupled
reaction with glutathione reductase by GPx Assay Kit
(Cayman, US). In this method, GPx reduces cumene
hydroperoxide during oxidation of GSH to GSSG. At this
moment, the total sample glutathione level is equal to
GSSG generated by addition of cumene hydroperoxide.
Next, the generated GSSG is reduced again to GSH by
glutathione reductase with consumption of NADPH. The
decrease in NADPH is proportional to the activity of GPx.
NADPH is quantified at the maximal absorbance at
340 nm. The assay was conducted on the fresh tissue
homogenate at 37 C, and the decrease in absorbance was
monitored for 7 min. The absorbance was measured by a
multiwell plate reader TECAN Infinite M200. The results
of this assay are presented as nmol NADPH/min/mg
protein.
Glutathione Reductase (GR) Activity
The activity of GR was determined by GR Assay Kit
(Cayman, US). The assay is based on the reaction catalyzed
by GR, in which GSSG is reduced to GSH, in turn NADPH
is oxidized to NADP?. The oxidation of NADPH is
accompanied by a decrease in absorbance at 340 nm and is
directly proportional to the activity of GR in the sample.
The assay was conducted on the fresh tissue homogenate
424 Neurotox Res (2014) 26:422–429
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The reaction was initiated by addition of NADPH into the
mixture of sample and GSSG and then the measurement of
absorbance at 340 nm was conducted for 5 min. The
results are presented as nmol NADPH/min/mg protein.
Lipid Peroxidation (MDA) Level
Colorimetric assay for lipid peroxidation was performed
using LPO-586 test (Bioxytech S.A.). The assay is based
on the reaction of the chromogenic reagent, N-methyl-2-
phenylindole, with one of the main products of the lipid
peroxidation malondialdehyde (MDA) at 45 C. The
reagent produces a violet 586 nm absorbing pigment with a
trimethine structure, a stable chromophore with maximal
absorbance at 586 nm, in hydrochloric acid. This type of
assay is more reliable than the reaction with tiobarbituric
acid in which heating up to 100 C is performed what can
induce de novo production of MDA and other products of
lipid peroxidation. The absorbance was measured by a
multiwell plate reader TECAN Infinite M200. Lipid per-
oxidation in samples was calculated from the standard
curve and is expressed as nmol of MDA/mg of protein.
Protein Concentration
Protein concentration was determined in the brain structure
homogenates using bicinchoninic acid (Smith et al. 1985).
This method combines reduction of Cu?2 to Cu?1 by protein
in an alkaline medium (the biuret reaction) with the colori-
metric detection of the cuprous cation (Cu?1) using the bi-
cinchoninic acid. The purple-colored reaction product of
this assay is formed by the chelation of two molecules of
BCA with one cuprous ion. This water-soluble complex
exhibits a strong absorbance at 562 nm, which is linear with
increasing protein concentrations. The absorbance was
measured by a multiwell plate reader TECAN Infinite M200.
Statistical Analysis
All data were expressed as the means (±SEM) from eight
samples assayed in triplicates. Statistical analyses were
performed with a one-way analysis of variance (ANOVA)
and next differences between groups were evaluated by the
Dunnett’s post-hock test. p \ 0.05 was considered as sta-
tistically significant.
Results
Total Antioxidant Capacity
Since EE and BE were dissolved and administered in saline
solution, whereas PHE in oil, so the results obtained from
animals treated with EE and BE were compared to SAL
group, while those derived from animals administered PHE
to OIL group. All the examined compounds were injected
in a dose of 2.5 mmol/kg (s.c.). It was found that 4-week
administration of PHE or BE inhibited the total antioxidant
activity in both brain regions, e.g. in the frontal cortex and
in the hippocampus (Fig. 1a, b). Among tested ethylene
glycol ethers, only EE did not change the total antioxidant
activity in any of the examined brain regions.
Lipid Peroxidation
In animals treated with PHE and BE, a significant increase
in lipid peroxidation in the frontal cortex was observed
(Fig. 2a), whereas in the hippocampus only BE evoked a
raise in the MDA concentration (Fig. 2b). There were no
significant changes in the lipid peroxidation after exposure
animals to EE in both, the hippocampus and frontal cortex.
Superoxide Dismutase Activity
In animals exposed to BE and PHE, the activity of SOD
decreased in the frontal cortex, whereas there was no
change in this parameter in rats treated with EE (Fig. 2c).
Interestingly, administration of all studied ethylene glycol
ethers elevated SOD activity in the hippocampus (Fig. 2d).
Catalase Activity
It has been found that none of the examined compounds
affected in a statistically significant manner catalase
activity either in the frontal cortex or in the hippocampus
(data not shown).
Glutathione Peroxidase Activity
In animals treated with PHE and BE, but not with EE, a
significant decrease in the activity of glutathione peroxi-
dase in the frontal cortex was observed (Fig. 2e). In the
hippocampus only PHE, but not EE and BE, significantly
attenuated activity of the investigated enzyme (Fig. 2f).
Glutathione Reductase Activity
All ethylene glycol ethers under study did no change glu-
tathione reductase activity in the frontal cortex and in the
hippocampus (Fig. 2g, h).
Discussion
The present data indicated that a long term administration
of BE and PHE reduced the total antioxidant activity and
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enhanced lipid peroxidation in the brain. Oxidative stress,
resulting from excessive production of free radicals in
relation to the capacity of their removal, is considered to be
the main cause leading to cell damage. Overproduction of
free radicals is particularly dangerous for the central ner-
vous system (CNS) cells, especially for neurons, which as
post-mitotic cells are particularly sensitive to the harmful
influences. Additionally, in the brain a large amount of free
radicals is formed not only as a result of normal aerobic
cellular metabolism but also due to metabolism of neuro-
transmitters, especially excitatory amino acids. Contribu-
tion of the oxidative stress to brain damage induced by
cerebral ischemia/reperfusion, traumatic brain injury or in
pathogenesis of neurodegenerative disorders has often been
reported (Sharma et al. 2014; Uttara et al. 2009). There is
also a mounting evidence that free radicals play an
important role in brain cell damage caused by a number of
xenobiotics. Previously, we found that administration of a
mixture of EGEs attenuated antioxidant potency in some
brain regions, however, because two compounds were
administered simultaneously, these data did not provide
information, which exactly EGE was responsible for this
effect (Pomierny et al. 2013). The present data showed that
EGEs with more lipophilic properties, e.g. BE and PHE
affected the total antioxidant activity and lipid peroxida-
tion, whereas the most hydrophilic compound—EE showed
no such action. The finding that the adverse effects of
EGEs on brain cells depends mainly on their lipophilicity is
in line with our previous in vitro study, which showed that
PHE, BE and IPE much more strongly damaged human
neuroblastoma cell line (SH-SY5Y cells) than the hydro-
philic EGEs did (Regulska et al. 2010).
To unify dermal passage of active compound through
the skin in the present research we administered EGEs by
the s.c. injection. The hydrophilic/lipophilic properties of
EE, BE, PHE are versatile, thus dermal administration
could have distracted absorption rate of particular EGEs.
Effectiveness of s.c. route of administration was confirmed
in the research of similar group of EGEs (Starek et al.
2008a) and stress induced by this method of administration
was negligible.
The aim of the present study was also to find out
whether changes in the total antioxidant activity and lipid
peroxidation in animals receiving PHE and BE were
associated with differences in the activity of antioxidant
enzymes present in these brain structures. Enzymatic and
non-enzymatic antioxidants are responsible for scavenging
free radicals, their precursors or inhibiting ROS produc-
tion mainly by binding metal ions involved in their syn-
thesis. Among enzymatic antioxidants, catalase, SOD and
GPX play an essential role in the initial stage of ROS
removal. In the frontal cortex, the decrease in the total
antioxidant activity, was accompanied by the reduction in
SOD and GPX activity. SOD catalyzes dismutation of
superoxide radical to hydrogen peroxide, which is next
detoxified by GPX and catalase. Thus, the reduction of
SOD activity induced by PHE and BE may be responsible
for toxic effect of superoxide radicals, while the decrease
in GPX can potentiate hydrogen peroxide-induced dam-
age. We did not observe any changes in catalase and
glutathione reductase activities but due to a relatively low
level of enzymatic antioxidants in the brain and high
susceptibility of this tissue to damage, it seems that the
decrease only in SOD and GPX may be sufficient to evoke
adverse effects in the frontal cortex. Accordingly,
enhancement of lipid peroxidation, one of the first signs of
free radical action on polyunsaturated fatty acids in bio-
logical membranes, was observed in the frontal cortex in
animals administered BE and PHE. The obtained results
clearly show that in the frontal cortex PHE and BE, but
not EE, reduce ability of enzymatic antioxidants to scav-
enge free radicals. In contrast to the frontal cortex, in the
hippocampus the reduced total antioxidant activity in
animals administered PHE and BE was not connected with
the reduction of the investigated antioxidant enzyme
activities. All examined EGEs increased SOD activity and
Fig. 1 The effect of EGE on the total antioxidant capacity in the
frontal cortex (a) and hippocampus (b). The results are shown as the
mean ± SEM from 8 tissue samples run in three repetitions. SAL
saline; EE 2-ethoxyethanol; BE 2-butoxyethanol; OIL sunflower oil;
PHE 2-phenoxyethanol. The significance of differences between the
means was evaluated by Dunnett’s test following the one way
analyses of variance (ANOVA); *p \ 0.05 versus SAL group;
#p \ 0.05, ##p \ 0.01 versus OIL group
426 Neurotox Res (2014) 26:422–429
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had no effect on catalase and GR. Only PHE significantly
attenuated GPX activity but this effect did not intensify
lipid peroxidation. On the other hand, BE which both
reduced the total antioxidant activity and increased lipid
peroxidation, did not reduce the activity of any of the
investigated enzymes and even enhanced SOD activity.
Thus, oxidative damage of lipids induced by this com-
pound probably resulted from its action on other enzymes
involved in free radical removal (e.g. glutathione
S-transferase) or on non-enzymatic antioxidants (e.g.
ascorbic acid, a-tocopherol, carotenoids). Most likely is
the impact of BE on vitamin D since it has been shown
that this compound strongly reduces vitamin E level in the
peripheral tissue (Park et al. 2002), however, such effect in
the brain has not been studied, yet. It is also possible that
SOD activation by BE and PHE may accelerate superox-
ide radical conversion to hydrogen peroxide, which under
constant catalase activity may not be sufficiently decom-
posed to H2O2 that altogether leads to an increase in the
hydroxyl radicals formation.
Fig. 2 The effect of particular
EGEs on the lipid peroxidation
in the frontal cortex (a) and
hippocampus (b). On figures
c and d the effect of particular
EGEs on the activity of
superoxide dismutase is shown
in frontal cortex and
hippocampus respectively. The
effect of particular EGEs on the
activity of glutathione
peroxidase is shown on figures
e for frontal cortex and f for the
hippocampus. The effect of
particular EGEs on the activity
of glutathione reductase is
shown on figures g and h for
frontal cortex and hippocampus
respectively. Results are shown
as the mean ± SEM from eight
tissue samples run in three
repetitions. SAL saline; EE
2-ethoxyethanol; BE
2-butoxyethanol; OIL sunflower
oil; PHE 2-phenoxyethanol. The
significance of differences
between the means was
evaluated by Dunnett’s test
following the one way analyses
of variance (ANOVA);
*p \ 0.05, **p \ 0.01,
***p \ 0.001 versus SAL
group; #p \ 0.05, ##p \ 0.01,
###p \ 0.001 versus OIL group
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Like in the present study, also attenuation of antioxidant
defense system and increase in lipid peroxidation appears
to be the mechanism of damaging EGE action on testicular
function (Adedara and Farombi 2010). Similarly, it has
been shown that BE administration induced oxidative
stress in the mouse liver and probably by this mechanism
BE increased liver tumor (Park et al. 2002). In that case,
BE increased oxidative stress in an indirect way, namely it
induced hemolysis which led to the accumulation of he-
mosiderin and free hemoglobin in the liver, next iron in
Fenton reaction exacerbated the formation of hydroxyl
radicals and induced liver neoplasia. However, the mech-
anism of EGE action in the brain has not been studied and
it cannot be concluded whether the exacerbation of lipid
peroxidation, observed in the present study, resulted from
the direct action of EGEs on antioxidant enzymes or it was
an indirect action, connected for instance with increase in
the ROS production, blocking metabolic cooperation
between brain cells or decrease in intracellular pH (Loch-
Caruso et al. 1984; Louisse et al. 2010). It has not been also
established whether neurotoxic EGE action is exerted by
the parent compound or as in the peripheral tissues by their
metabolites, mainly alkoxyacetic acids. Currently, we
believe that the neurotoxic effects of these compounds
depend mainly on their lipophilicity which determines their
penetration to the brain. However, this assumption is not
supported by determination of the level of these com-
pounds and their metabolites in CNS.
In conclusion, the present study indicated that the most
lipophilic EGEs induced oxidative stress and enhanced
lipid peroxidation in the rat frontal cortex and hippocam-
pus. In the frontal cortex, but not in the hippocampus, the
adverse effects of EGEs were likely to be connected with
inhibition of SOD and GPX activity. Thus, excessive
exposure to EGEs can induce or exacerbate brain cell
damage and consequently these compounds may play a
role in pathogenesis of neurodegenerative disorders.
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